AKR1B10
Reactivité: Humain, Souris, Rat
WB, IHC, IHC (p), ICC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Peptide ELISA: 1/8000. Western Blot: 0.03 - 0.1 μg/mL. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions
For Research Use only
Concentration
0,5 mg/mL
Buffer
Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
Avoid repeated freezing and thawing.
Stock
4 °C/-20 °C
Stockage commentaire
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
Díez-Dacal, Gayarre, Gharbi, Timms, Coderch, Gago, Pérez-Sala: "Identification of aldo-keto reductase AKR1B10 as a selective target for modification and inhibition by prostaglandin A(1): implications for antitumoral activity." dans: Cancer research, Vol. 71, Issue 12, pp. 4161-71, (2011) (PubMed).
Antigène
AKR1B10
(Aldo-Keto Reductase Family 1, Member B10 (Aldose Reductase) (AKR1B10))
anticorps AKR1B11, anticorps AKR1B12, anticorps ALDRLn, anticorps ARL-1, anticorps ARL1, anticorps HIS, anticorps HSI, anticorps 2310005E10Rik, anticorps Akr1b16, anticorps AKR, anticorps AKR1B10, anticorps Akr1b10, anticorps aldo-keto reductase family 1 member B10, anticorps aldo-keto reductase family 1, member B10 (aldose reductase), anticorps aldo-keto reductase family 1 member B10-like 2, anticorps AKR1B10, anticorps Akr1b10, anticorps AKR1B10L2, anticorps LOC100585902, anticorps LOC100723118, anticorps LOC101107697
Sujet
ARK1B10 is a NADPH dependant enzyme with an ability to efficiently reduce aliphatic and aromatic aldehydes. A 316 A.A protein, AKR1B10 is a highly efficient retinal reductase constituting the first cytosolic NADP (H) dependent retinal reductase described in humans and is characterized by the presence of a novel NADP binding motif. Due to its ability to convert glucose to sorbitol, AKR1B10 may have a role in development of secondary diabetic complications. It is abundantly expressed in adrenal gland, small intestine and colon, with lower levels in liver, thymus, prostate, testis, and skeletal muscle and its levels are up regulated in certain cancers such as hepatocellular carcinoma.Synonyms: AKR1B11, ARL-1, Aldo-keto reductase family 1 member B10, Aldose reductase-like, Aldose reductase-related protein, Small intestine reductase